Benefits of pharmacogenomics in drug development-earlier launch of drugs and less adverse events

Wataru Ohashi, Hiroshi Tanaka

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Benefits of pharmacogenomics in drug development-earlier launch of drugs and less adverse events'. Together they form a unique fingerprint.

Social Sciences

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions

Biochemistry, Genetics and Molecular Biology

Neuroscience